Gene therapy has emerged as a cutting-edge modality with transformative potential for treating a broad range of genetic disorders. Despite significant advancements, the purification and separation of ...
In the slowly evolving landscape of bioprocess development and manufacturing, digital bioprocess-twins have emerged as potential accelerators. While advanced algorithms are at the heart of this ...
COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, announced results of a collaborative research program between IonQ, AstraZeneca, ...
A study led by researchers from A*STAR's Singapore Institute for Clinical Sciences (SICS) has found evidence suggesting that children exposed to elevated levels of early life adversity (ELA) exhibit ...
* ALNYLAM PHARMACEUTICALS INC - COMPANY INTENDS TO INITIATE LUMASIRAN PHASE 3 STUDY IN MID-2018, WITH TOPLINE RESULTS EXPECTED IN 2019 * ALNYLAM PHARMACEUTICALS INC - IF LUMASIRAN PHASE 3 STUDY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results